Immunosuppressant
Immunosuppressant medicines are a class of drugs that overpower, reduce, the strength of the body’s immune system. Particular of these drugs are used towards make the build less possible to reject a transplanted organ, such as a liver, heart, or kidney. These drugs are called antirejection drugs. Immunosuppressant drugs are frequently used to treat autoimmune disorders such as lupus, psoriasis, and rheumatoid pain. If your doctor has approved an immunosuppressant medication for you, here’s about drugs do, hey work, and they might make you feel. Nearly everyone accepts an organ transplant must take immunosuppressant drugs. This is because your immune system understands a transplanted organ as a foreign object.
Related Conference of Immunosuppressant
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Immunosuppressant Conference Speakers
Recommended Sessions
- Cyclosporine
- Drug Delivery in Transplantation
- Heart transplant
- Immunosuppressant
- Kaposi Sarcoma in case of solid organ transplantation
- Kidney transplant
- Lung transplant
- Medicine - Surgery
- Organ Donation
- Organ Rejection
- Organ Transplantation
- Organ Transplantation Market to Ascent Exponentially
- Skin & Tissue Grafting
- Stem Cell Transplantation
- Transplant Survival and Transplant Living
- Transplantation Special legal and Ethical problems
- Trends in Organ Transplantation
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)